aluates Reports

$ 0.0

Automative

Global Tardive Dyskinesia (TD) Treatment Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-37T853

Global Tardive Dyskinesia TD Treatment Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Tardive Dyskinesia (TD) Treatment Drugs Market Research Report 2025

Code: QYRE-Auto-37T853

Report

July 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Neurocrine Biosciences Inc

Teva Pharmaceutical Industries

Pfizer Inc

Biogen

Novartis

Astrazeneca plc

GlaxoSmithKline PLC

Bayer

Sanofi

Tardive Dyskinesia (TD) Treatment Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Tardive Dyskinesia (TD) Treatment Drugs Market

The global market for Tardive Dyskinesia (TD) Treatment Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive dyskinesia is difficult to treat as treatment process is also not confirmed and the drug is also not approved in various conditions. The treatment of tardive dyskinesia is directly affect the neurological system of the respective patients. This disorder may commonly occurs in smoker than non-smoker, and also in the patient of depression, anxiety disorder and others.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Tardive Dyskinesia (TD) Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tardive Dyskinesia (TD) Treatment Drugs.

The Tardive Dyskinesia (TD) Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tardive Dyskinesia (TD) Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tardive Dyskinesia (TD) Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tardive Dyskinesia (TD) Treatment Drugs Market Report

Report Metric	Details
Report Name	Tardive Dyskinesia (TD) Treatment Drugs Market
CAGR	5%
Segment by Type	Valbenazine Deutetrabenazine
Segment by Application	Hospitals Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Neurocrine Biosciences, Inc., Teva Pharmaceutical Industries, Pfizer Inc., Biogen, Novartis AG, AstraZeneca, GlaxoSmithKline plc., Bayer AG, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tardive Dyskinesia (TD) Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tardive Dyskinesia (TD) Treatment Drugs Market report?

Ans: The main players in the Tardive Dyskinesia (TD) Treatment Drugs Market are Neurocrine Biosciences, Inc., Teva Pharmaceutical Industries, Pfizer Inc., Biogen, Novartis AG, AstraZeneca, GlaxoSmithKline plc., Bayer AG, Sanofi

What are the Application segmentation covered in the Tardive Dyskinesia (TD) Treatment Drugs Market report?

Ans: The Applications covered in the Tardive Dyskinesia (TD) Treatment Drugs Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Tardive Dyskinesia (TD) Treatment Drugs Market report?

Ans: The Types covered in the Tardive Dyskinesia (TD) Treatment Drugs Market report are Valbenazine, Deutetrabenazine

Recommended Reports

Neurological Disorders

Psychiatric Disorders

Addiction & Behavioral

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Valbenazine

1.2.3 Deutetrabenazine

1.3 Market by Application

1.3.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Perspective (2020-2031)

2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Growth Trends by Region

2.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Region (2020-2025)

2.2.3 Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Region (2026-2031)

2.3 Tardive Dyskinesia (TD) Treatment Drugs Market Dynamics

2.3.1 Tardive Dyskinesia (TD) Treatment Drugs Industry Trends

2.3.2 Tardive Dyskinesia (TD) Treatment Drugs Market Drivers

2.3.3 Tardive Dyskinesia (TD) Treatment Drugs Market Challenges

2.3.4 Tardive Dyskinesia (TD) Treatment Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Revenue

3.1.1 Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Revenue (2020-2025)

3.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Tardive Dyskinesia (TD) Treatment Drugs Revenue

3.4 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio

3.4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2024

3.5 Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs Head office and Area Served

3.6 Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Product and Application

3.7 Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tardive Dyskinesia (TD) Treatment Drugs Breakdown Data by Type

4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Type (2020-2025)

4.2 Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Type (2026-2031)

5 Tardive Dyskinesia (TD) Treatment Drugs Breakdown Data by Application

5.1 Global Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Application (2020-2025)

5.2 Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2020-2031)

6.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2020-2025)

6.4 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size (2020-2031)

7.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2020-2025)

7.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size (2020-2031)

8.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2020-2031)

9.2 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2020-2025)

9.4 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size (2020-2031)

10.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Neurocrine Biosciences, Inc.

11.1.1 Neurocrine Biosciences, Inc. Company Details

11.1.2 Neurocrine Biosciences, Inc. Business Overview

11.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.1.4 Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

11.1.5 Neurocrine Biosciences, Inc. Recent Development

11.2 Teva Pharmaceutical Industries

11.2.1 Teva Pharmaceutical Industries Company Details

11.2.2 Teva Pharmaceutical Industries Business Overview

11.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.2.4 Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

11.2.5 Teva Pharmaceutical Industries Recent Development

11.3 Pfizer Inc.

11.3.1 Pfizer Inc. Company Details

11.3.2 Pfizer Inc. Business Overview

11.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.3.4 Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

11.3.5 Pfizer Inc. Recent Development

11.4 Biogen

11.4.1 Biogen Company Details

11.4.2 Biogen Business Overview

11.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.4.4 Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

11.4.5 Biogen Recent Development

11.5 Novartis AG

11.5.1 Novartis AG Company Details

11.5.2 Novartis AG Business Overview

11.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.5.4 Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

11.5.5 Novartis AG Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.6.4 AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 GlaxoSmithKline plc.

11.7.1 GlaxoSmithKline plc. Company Details

11.7.2 GlaxoSmithKline plc. Business Overview

11.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.7.4 GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

11.7.5 GlaxoSmithKline plc. Recent Development

11.8 Bayer AG

11.8.1 Bayer AG Company Details

11.8.2 Bayer AG Business Overview

11.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.8.4 Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

11.8.5 Bayer AG Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Details

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Introduction

11.9.4 Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

11.9.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Neurocrine Biosciences Inc

Teva Pharmaceutical Industries

Pfizer Inc

Biogen

Novartis

Astrazeneca plc

GlaxoSmithKline PLC

Bayer

Sanofi

List of Tables

Table 1. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Valbenazine

Table 3. Key Players of Deutetrabenazine

Table 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region (2020-2025)

Table 8. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region (2026-2031)

Table 10. Tardive Dyskinesia (TD) Treatment Drugs Market Trends

Table 11. Tardive Dyskinesia (TD) Treatment Drugs Market Drivers

Table 12. Tardive Dyskinesia (TD) Treatment Drugs Market Challenges

Table 13. Tardive Dyskinesia (TD) Treatment Drugs Market Restraints

Table 14. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Players (2020-2025)

Table 16. Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2024)

Table 17. Ranking of Global Top Tardive Dyskinesia (TD) Treatment Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Headquarters and Area Served

Table 20. Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Product and Application

Table 21. Global Key Players of Tardive Dyskinesia (TD) Treatment Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Neurocrine Biosciences, Inc. Company Details

Table 47. Neurocrine Biosciences, Inc. Business Overview

Table 48. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product

Table 49. Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025) & (US$ Million)

Table 50. Neurocrine Biosciences, Inc. Recent Development

Table 51. Teva Pharmaceutical Industries Company Details

Table 52. Teva Pharmaceutical Industries Business Overview

Table 53. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product

Table 54. Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025) & (US$ Million)

Table 55. Teva Pharmaceutical Industries Recent Development

Table 56. Pfizer Inc. Company Details

Table 57. Pfizer Inc. Business Overview

Table 58. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product

Table 59. Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025) & (US$ Million)

Table 60. Pfizer Inc. Recent Development

Table 61. Biogen Company Details

Table 62. Biogen Business Overview

Table 63. Biogen Tardive Dyskinesia (TD) Treatment Drugs Product

Table 64. Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025) & (US$ Million)

Table 65. Biogen Recent Development

Table 66. Novartis AG Company Details

Table 67. Novartis AG Business Overview

Table 68. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product

Table 69. Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025) & (US$ Million)

Table 70. Novartis AG Recent Development

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product

Table 74. AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025) & (US$ Million)

Table 75. AstraZeneca Recent Development

Table 76. GlaxoSmithKline plc. Company Details

Table 77. GlaxoSmithKline plc. Business Overview

Table 78. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product

Table 79. GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025) & (US$ Million)

Table 80. GlaxoSmithKline plc. Recent Development

Table 81. Bayer AG Company Details

Table 82. Bayer AG Business Overview

Table 83. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product

Table 84. Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025) & (US$ Million)

Table 85. Bayer AG Recent Development

Table 86. Sanofi Company Details

Table 87. Sanofi Business Overview

Table 88. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product

Table 89. Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025) & (US$ Million)

Table 90. Sanofi Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Tardive Dyskinesia (TD) Treatment Drugs Picture

Figure 2. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type: 2024 VS 2031

Figure 4. Valbenazine Features

Figure 5. Deutetrabenazine Features

Figure 6. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Tardive Dyskinesia (TD) Treatment Drugs Report Years Considered

Figure 12. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region: 2024 VS 2031

Figure 15. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Players in 2024

Figure 16. Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2024

Figure 18. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2020-2031)

Figure 20. United States Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2020-2031)

Figure 24. Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region (2020-2031)

Figure 32. China Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2020-2031)

Figure 40. Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2020-2031)

Figure 44. Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Neurocrine Biosciences, Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

Figure 48. Teva Pharmaceutical Industries Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

Figure 49. Pfizer Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

Figure 50. Biogen Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

Figure 51. Novartis AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

Figure 52. AstraZeneca Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

Figure 53. GlaxoSmithKline plc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

Figure 54. Bayer AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

Figure 55. Sanofi Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Tardive Dyskinesia Treatment Market Research Report 2024

Tardive Dystonia Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tardive Dystonia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030

Tourette Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tourette Syndrome Drug Market Research Report 2024

Global Diabetic Neurological Disorder Therapeutic Drug Market Insights Forecast to 2030

Global Addictions Therapeutics Market Insights Forecast to 2030

Valbenazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Disruptive Behavior Disorder DBD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dystonia Drugs Market Research Report 2025

Global Learning Disability Treatment Market Insights Forecast to 2030

Deutetrabenazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stuttering Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antipsychotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neuroleptics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tiapride Market Insights Forecast to 2030

Global Frontotemporal Dementia Treatment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions